9 profiles
Native domain record
NSD3 PWWP1
Histone-lysine N-methyltransferase NSD3
Canonical sequence · Source-mapped regions
Protein domain architecture
PWWP annotation cores, other annotated regions, and deposited construct mappings share the canonical amino acid axis. The original Atlas PWWP intervals retain their source definitions.
7 additional source-supported regions · coordinates and evidence
UniProt feature coordinates accepted after exact canonical sequence identity check against the frozen Atlas. Source annotations can be inferred by sequence or curated from experiments; evidence codes remain attached. Other domain types link to their UniProt source because the Atlas records PWWP domains.
| Source feature | Type | Amino acids | Evidence |
|---|---|---|---|
| PHD-type 1 | Zinc finger | 701–748 | ECO:0000255 PROSITE-ProRule: PRU00146 |
| PHD-type 2 | Zinc finger | 749–805 | ECO:0000255 PROSITE-ProRule: PRU00146 |
| PHD-type 3 | Zinc finger | 862–955 | ECO:0000255 PROSITE-ProRule: PRU00146 |
| AWS | Domain | 1093–1143 | ECO:0000255 PROSITE-ProRule: PRU00562 |
| SET | Domain | 1145–1262 | ECO:0000255 PROSITE-ProRule: PRU00190 |
| Post-SET | Domain | 1269–1285 | ECO:0000255 PROSITE-ProRule: PRU00155 |
| PHD-type 4; atypical | Zinc finger | 1321–1368 | ECO:0000255 PROSITE-ProRule: PRU00146 |
Deposited construct mapping
4 selected examplesColored segments map deposited polymer sequences to this canonical protein; dark segments have observed coordinates. Unmapped tags and engineered residues are not assigned canonical positions. These are not certified whole-fold boundaries.
Mapping and construct evidence
Deposited polymer length: 136 residues. Mapped sequence identity: 100.0%. no sequence difference detected by mapping; not proof of wild type.
PWWP1: 64 / 64 annotation-core Cα residues observed.
Frozen SIFTS aligned regions with construct-to-UniProt sequence comparison. Bars are mapped canonical segments; tags, insertions, and unmapped termini are not assigned canonical positions. PDB source.
Mapping and construct evidence
Deposited polymer length: 113 residues. Mapped sequence identity: 100.0%. sequence differences or tags detected; biological versus engineered origin requires review.
PWWP2: 63 / 63 annotation-core Cα residues observed.
Frozen SIFTS aligned regions with construct-to-UniProt sequence comparison. Bars are mapped canonical segments; tags, insertions, and unmapped termini are not assigned canonical positions. PDB source.
Unmapped construct positions: 1–1.
Mapping and construct evidence
Deposited polymer length: 110 residues. Mapped sequence identity: 100.0%. sequence differences or tags detected; biological versus engineered origin requires review.
PWWP2: 63 / 63 annotation-core Cα residues observed.
Frozen SIFTS aligned regions with construct-to-UniProt sequence comparison. Bars are mapped canonical segments; tags, insertions, and unmapped termini are not assigned canonical positions. PDB source.
Unmapped construct positions: 1–7, 105–110.
Mapping and construct evidence
Deposited polymer length: 153 residues. Mapped sequence identity: 100.0%. sequence differences or tags detected; biological versus engineered origin requires review.
PWWP1: 64 / 64 annotation-core Cα residues observed.
Frozen SIFTS aligned regions with construct-to-UniProt sequence comparison. Bars are mapped canonical segments; tags, insertions, and unmapped termini are not assigned canonical positions. PDB source.
Unmapped construct positions: 1–1.
One mapped example per native domain, preferring frozen experimental representatives; up to four distinct mapped intervals.
Validated isoform differences · 8 PWWP correspondence records
Only source-validated PWWP core correspondences from the frozen v1.2 isoform audit; other-domain architectures are not projected onto isoforms. Coordinates in the isoform column refer to the individual isoform sequence; deleted cores remain absent.
| Isoform | Length | PWWP core | Source-mapped positions | Retention / source edits |
|---|---|---|---|---|
| Q9BZ95-2 | 1388 | PWWP1 | 270–333 64 / 64 mapped residues; span may contain gaps | complete |
| Q9BZ95-2 | 1388 | PWWP2 | 911–973 63 / 63 mapped residues; span may contain gaps | complete |
| Q9BZ95-3 | 645 | PWWP1 | 270–333 64 / 64 mapped residues; span may contain gaps | complete |
| Q9BZ95-3 | 645 | PWWP2 | None | absent |
| Q9BZ95-4 | 1374 | PWWP1 | 207–270 64 / 64 mapped residues; span may contain gaps | complete |
| Q9BZ95-4 | 1374 | PWWP2 | 897–959 63 / 63 mapped residues; span may contain gaps | complete |
| Q9BZ95-5 | 1426 | PWWP1 | 270–333 64 / 64 mapped residues; span may contain gaps | complete |
| Q9BZ95-5 | 1426 | PWWP2 | 960–1022 63 / 63 mapped residues; span may contain gaps | complete |
Canonical annotation interval 270–333 · UniProtKB reviewed feature. annotation core; not a certified complete folded domain or pocket.
Alternative PWWP annotations and interval provenance
[
{
"end": 331,
"identifier": "SM00293",
"integrated_identifier": "IPR000313",
"model": "SM00293",
"name": "domain with conserved PWWP motif",
"representative": false,
"score": 1.7e-12,
"source": "smart",
"source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q9BZ95/?page_size=200",
"start": 268
},
{
"end": 349,
"identifier": "IPR000313",
"integrated_identifier": null,
"model": null,
"name": "PWWP domain",
"representative": false,
"score": null,
"source": "interpro",
"source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q9BZ95/?page_size=200",
"start": 268
},
{
"end": 397,
"identifier": "IPR047451",
"integrated_identifier": null,
"model": null,
"name": "Histone-lysine N-methyltransferase NSD3, first PWWP domain",
"representative": false,
"score": null,
"source": "interpro",
"source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q9BZ95/?page_size=200",
"start": 268
},
{
"end": 397,
"identifier": "cd20163",
"integrated_identifier": "IPR047451",
"model": "cd20163",
"name": "first PWWP domain found in nuclear SET domain-containing protein 3 (NSD3) and similar proteins",
"representative": false,
"score": 1.673e-91,
"source": "cdd",
"source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q9BZ95/?page_size=200",
"start": 268
},
{
"end": 333,
"identifier": "PS50812",
"integrated_identifier": "IPR000313",
"model": "PS50812",
"name": "PWWP domain profile",
"representative": false,
"score": null,
"source": "profile",
"source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q9BZ95/?page_size=200",
"start": 270
},
{
"end": 349,
"identifier": "PF00855",
"integrated_identifier": "IPR000313",
"model": "PF00855",
"name": "PWWP domain",
"representative": false,
"score": 7.1e-15,
"source": "pfam",
"source_url": "https://www.ebi.ac.uk/interpro/api/entry/all/protein/uniprot/Q9BZ95/?page_size=200",
"start": 271
}
]PWWP1 · source-classified Phase 6A evidence
Ligands & Bioactivity
19 chemical or preparation profiles · 13 domain-attributed assay / association observations. Counts refer to the curated snapshot.
8 profiles
Studied without research structure
compound 11 (Collie 2025)1 observations · 0 research-ligand entriescompound 12 (Collie 2025)1 observations · 0 research-ligand entriescompound 13 (Collie 2025)1 observations · 0 research-ligand entriescompound 5 (Collie 2025)1 observations · 0 research-ligand entriescompound 6 (Collie 2025)1 observations · 0 research-ligand entriescompound 7 (Collie 2025)1 observations · 0 research-ligand entriesMS97151 observations · 0 research-ligand entriesUNC69341 observations · 0 research-ligand entries2 profiles
Experiment-specific controls
BI-94661 observations · 0 research-ligand entriesMS9715N1 observations · 0 research-ligand entries0 profiles
Ambiguous / indirect evidence
No records in this category for the selected domain in the curated snapshot.
1 other deposited components in this domain (not pharmacological ligands)
Buffers, ions, cryoprotectants and solvents remain recorded as deposited chemical components.
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID · Other PDB component · not a studied ligand3 protein-level observations — no specific PWWP-domain attribution
These observations concern NSD3 in its reported experimental context. They are excluded from the selected domain's measurement counts.
- MS9715 · Immunoblot degradation · = 4.9 ± 0.4 µM · PMID:34469831
- MS9715 · Immunoblot degradation · > 80 percent · PMID:34469831
- MS9715N · Immunoblot degradation control · No NSD3 depletion observed in the matched control comparison. · PMID:34469831
Phase 6B · newly investigated source evidence
Additional experimental observations
No newly accepted exact-domain observations for this specific PWWP instance.
9 source-reported NSD3 PWWP results with an unresolved domain instance
PWWP1/PWWP2 attribution and the actual purified construct are not verified. These are excluded from exact-domain counts.
No new unmodified parent binary PWWP-bound PDB structure is claimed for these entries. Original Phase 5/6A numbers remain unchanged.
PWWP1 · Deposited coordinates
Experimental coverage and AlphaFold correspondence
One representative chain per PDB entry and native domain. RMSD uses fixed UniProt correspondence and all common Cα atoms; it is reported only for ≥40 atoms and ≥80% core coverage. A value is descriptive, not a prediction benchmark.
| PDB | Chain | Observed core Cα | Class | Method / resolution | AF RMSD Å | Review |
|---|---|---|---|---|---|---|
| 6G24 | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 2.1 Å | 0.679 | No classification flag |
| 6G25 | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.432 Å | 0.512 | No classification flag |
| 6G27 | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.65 Å | 0.389 | No classification flag |
| 6G29 | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.7 Å | 0.423 | No classification flag |
| 6G2B | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.61 Å | 0.444 | No classification flag |
| 6G2C | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.76 Å | 0.461 | No classification flag |
| 6G2E | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.85 Å | 0.465 | No classification flag |
| 6G2F | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.74 Å | 0.455 | No classification flag |
| 6G2O | A | 64 / 64 | Co-Crystals | X-RAY DIFFRACTION 1.81 Å | 0.474 | No classification flag |
| 6G3P | A | 64 / 64 | APO | X-RAY DIFFRACTION 2.8 Å | 0.701 | No classification flag |
| 6G3T | A | 64 / 64 | APO | X-RAY DIFFRACTION 2.53 Å | 0.663 | No classification flag |
PWWP1 · Measured preparations
Frozen v1.2 assay records
This retained table is the original source projection. The Phase 5 Ligands & Bioactivity section above includes added observations and reviewed target context. Values remain attached to their assay, construct and preparation. A crystal structure does not transfer affinity to another construct or stereoisomer. Assay pages preserve field-level source-verification states where reviewed; unreviewed null fields remain uncurated.
| Preparation / identity | Assay and result | Construct | Evidence and source |
|---|---|---|---|
| BI-9321 exact single CCD identity | SPR Kd = 166.0 nM ± 3.0 direct binding affinity | 263–398 | PMID:31285596 Phase 3 actual publisher Supplementary Table 7 and official Figure 3/4 captions; selected indexed accepted-manuscript Methods, full PDF unavailable (403); developer identity page Primary replicate conflict: Figure 3a states n=3 independent experiments, while Supplementary Table 7 states SPR n=4; both report SD. Indexed primary SPR Methods supply residues 263–398 and buffer, but the full PDF was unavailable. Exact assay temperature, mutations and per-dose contact times remain not inspected. Assay conditions and interpretation{} Primary developer website; original full article assay table was not retrieved. |
| BI-9321 exact single CCD identity | NanoBRET IC50 = 1.2 µM ± 0.06 cellular interaction response | Uncurated | PMID:31285596 Phase 3 actual publisher Supplementary Table 7 and official Figure 3/4 captions; selected indexed accepted-manuscript Methods, full PDF unavailable (403); developer identity page The value 1.2 ± 0.06 uM, SD and n=3 were verified in the actual Supplementary Table 7. Full NanoBRET construct and conditions were not inspected. The 1.4 uM direct tracer-engagement endpoint is separate from this histone PPI assay. Assay conditions and interpretation{"cell_line": "U2OS"} Interpretation not recorded in this snapshot. |
| UNC6934 exact single CCD identity | SPR Kd counter-screen > 30.0 µM censored binding limit | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
| compound 11 (Collie 2025) assayed stereoisomeric mixture not single chemical identity | SPR Kd counter-screen No binding negative binding test | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
| compound 12 (Collie 2025) paper label exact identity unresolved | SPR Kd counter-screen No binding negative binding test | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
| compound 13 (Collie 2025) paper label exact identity unresolved | SPR Kd counter-screen No binding negative binding test | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
| compound 5 (Collie 2025) assayed stereoisomeric mixture not single chemical identity | SPR Kd counter-screen > 30.0 µM censored binding limit | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
| compound 6 (Collie 2025) paper label exact identity unresolved | SPR Kd counter-screen > 30.0 µM censored binding limit | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
| compound 7 (Collie 2025) exact single CCD identity | SPR Kd counter-screen > 30.0 µM censored binding limit | 263–398 | PMID:40959233 Phase 3 primary Table 1 and actual supporting PDF pages 7, 9 and 14; the inherited HTRF method remains explicitly not inspected Assay-specific buffer and temperature verified from SI page 9; tag/construct from Table S2. Exact per-row kinetic-versus-steady-state fit choice and exact n beyond table footnote not specified. Chemical preparation identity remains as curated. Assay conditions and interpretation{"assay_substitutions": "not listed for assay constructs; 9FOE crystallographic mutants kept separate", "phase3_verification": "SV05A/SV05B", "protein_construct": "NSD3 263–398", "purified_tags": "N-terminal 6His-TEV retained"} Single counter-target experiment; not evidence of proteome-wide selectivity. No-binding rows have no inferred numerical threshold. |
PWWP1 · Prediction evidence
Predicted models
Domain retention uses independently reconstructed UniProt isoform edits. Local pLDDT is not experimental confirmation and does not establish interdomain orientation.
| Model | Origin | Core retention | Core mean pLDDT | Full mean pLDDT | Cautions |
|---|---|---|---|---|---|
| AF-Q9BZ95-F1:v6 Canonical | GDM | complete | 89.4 | 61.9 | |
| AF-Q9BZ95-2-F1:v6 | GDM | complete | 90 | 63.8 | |
| AF-Q9BZ95-3-F1:v6 | GDM | complete | 93.9 | 54.6 | |
| AF-Q9BZ95-4-F1:v6 | GDM | complete | 89.7 | 63.6 | |
| AF-Q9BZ95-5-F1:v6 | GDM | complete | 89.4 | 61.5 |
PWWP1 · Structural correspondence
Human annotation-core comparisons
Structural alignment establishes a residue correspondence for these cropped cores. It does not establish equivalent ligand pockets, function or selectivity.
| Domain pair | Aligned Cα | US-align RMSD Å | TM score A / B | View |
|---|---|---|---|---|
| ARID4A PWWP1 NSD3 PWWP1 | 56 | 2.17 | 0.5 / 0.68 | Aligned core viewer |
| BRD1 PWWP1 NSD3 PWWP1 | 57 | 2.21 | 0.563 / 0.707 | Aligned core viewer |
| BRPF1 PWWP1 NSD3 PWWP1 | 59 | 2.12 | 0.595 / 0.752 | Aligned core viewer |
| BRPF3 PWWP1 NSD3 PWWP1 | 59 | 2.06 | 0.593 / 0.746 | Aligned core viewer |
| DNMT3A PWWP1 NSD3 PWWP1 | 56 | 1.7 | 0.794 / 0.74 | Aligned core viewer |
| DNMT3B PWWP1 NSD3 PWWP1 | 56 | 1.68 | 0.784 / 0.732 | Aligned core viewer |
| HDGF PWWP1 NSD3 PWWP1 | 53 | 2.44 | 0.653 / 0.608 | Aligned core viewer |
| HDGFL2 PWWP1 NSD3 PWWP1 | 56 | 1.96 | 0.791 / 0.727 | Aligned core viewer |
| HDGFL3 PWWP1 NSD3 PWWP1 | 56 | 1.96 | 0.774 / 0.713 | Aligned core viewer |
| MSH6 PWWP1 NSD3 PWWP1 | 63 | 1.62 | 0.839 / 0.828 | Aligned core viewer |
| NSD2 PWWP1 NSD3 PWWP1 | 63 | 0.98 | 0.922 / 0.936 | Aligned core viewer |
| NSD3 PWWP1 NSD3 PWWP2 | 55 | 2.4 | 0.661 / 0.669 | Aligned core viewer |
| NSD3 PWWP1 PSIP1 PWWP1 | 56 | 2.53 | 0.654 / 0.654 | Aligned core viewer |
| NSD3 PWWP1 PWWP2B PWWP1 | 56 | 2.09 | 0.741 / 0.773 | Aligned core viewer |
| NSD3 PWWP1 PWWP3A PWWP1 | 53 | 2.17 | 0.627 / 0.643 | Aligned core viewer |
| NSD3 PWWP1 ZMYND11 PWWP1 | 52 | 1.85 | 0.697 / 0.833 | Aligned core viewer |
| NSD3 PWWP1 ZMYND8 PWWP1 | 51 | 1.44 | 0.693 / 0.839 | Aligned core viewer |